2025

In recent years, the life sciences sector has faced mounting pressures from capital market volatility, regulatory scrutiny and evolving patient data standards. With a noticeable uptick in financial distress and a decline in successful bankruptcy resolutions, stakeholders are grappling with existential questions about sustainability, compliance, and trust. Bringing together finance, legal, operational and regulatory perspectives, this session will provide attendees with practical insights into how companies can manage risk, preserve value and protect trust – even under duress.

This panel will examine key regulatory developments affecting the health care sector, including recent policy changes, enforcement trends, compliance challenges and stakeholder decision-making, as well as how shifting regulations are influencing restructuring strategies and creditor recoveries.

This keynote will discuss how a health care futures market could help stabilize costs for payers and providers, and will explore various financial tools and incentives that could help make health care more predictable and investable. This in-depth talk also will examine the convergence of biology and technology into investable frontiers in medicine — and steps that practitioners can take now to preserve innovation while helping to fix broken balance sheets.

This session will explore how artificial intelligence (AI) is transforming health care, from diagnostics and treatment-planning to operational efficiency, and will address the ethical, regulatory and human-centered challenges AI brings about. The panelists will discuss how advancements in AI can enhance clinical decision-making, diagnostics and personalized care while maintaining ethical and patient-centered practices, and will evaluate practical strategies for integrating AI tools into health care workflows based on real-world applications, challenges and lessons learned.

In this session, former and active hospital and senior-living CEOs/CFOs will speak on hot topics in health care, and how they affect the successes of day-to-day operations.

The Bankruptcy Abuse Prevention and Consumer Protection Act of 2005 (BAPCPA) was implemented on Oct. 17, 2005. This panel of experts will provide their perspectives on the impacts of the law on consumer and business bankruptcies in the 20 years since the law went into effect. John Penn of Perkins Coie (Dallas), who served as ABI's president when BAPCPA became law, will be joined by two former bankruptcy judges who were on the bench at the time of the law's implementation to discuss the developments brought about by BAPCPA, and to share their views on potential bankruptcy law reforms moving forward.

Hosted by the Asset Sales CommitteePost-confirmation fiduciaries (trustees, plan administrators and wind-down officers) typically have discrete residual assets that need to be monetized. This webinar will discuss monetizing life insurance policies, partnership interests, judgments, litigation, and other known or unknown remnant assets.

ABI’s Bankruptcy 2025: Views from the Bench program is a unique opportunity for bankruptcy practitioners to hear from more than 20 sitting and retired bankruptcy judges during a full day of high-quality CLE and networking opportunities. The program was recorded in the historic National Press Club building. Nestled in the heart of downtown Washington between the White House, Washington Monument and Capitol Hill with easy access to Metro, parking and hotels, the National Press Club offers a unique setting like no other.

This session will explore key ethical issues facing bankruptcy practitioners and judges, including professional responsibility, conflicts of interest, confidentiality, and duties to clients, creditors and the court. The panelists will examine recent case law, evolving ethical standards, and practical guidance for navigating complex situations in bankruptcy practice.

This session will cover pending pertinent U.S. Supreme Court and appellate cases, as well as recently decided cases.